SCHEMBL983428

SCHEMBL983428

O=CCCc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29951184 0.88 ALDH1A1 (0.58) —
SCHEMBL6678670 0.86 ALDH1A1 (0.66) —
SCHEMBL17731767 0.84 ALDH1A1 (0.69) —
SCHEMBL7965354 0.83 — —
SCHEMBL2003566 0.79 CHRM2 (0.52) —
Hexanal SCHEMBL15269935 0.79 ALDH1A1 (0.57) —
SCHEMBL4652397 0.78 — —
SCHEMBL6827852 0.78 — —
SCHEMBL7956949 0.78 — —
SCHEMBL8146532 0.78 ALDH1A1 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0126625-A2 Method for the production of phenolic compounds and resins SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-11-28 — — EP claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 — — EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 — — WO disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 — — WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 — — US disclosed
EP-2473486-B2 PYRIMIDINES AS HEPCIDINE ANTAGONISTS VIFOR INT AG (CH) 2021-09-22 — — EP disclosed
CN-112939790-A Method for preparing tertiary amine organic compound by decomposing substituted formamide under mild condition 天津理工大学 2021-06-11 — — CN disclosed
CN-112174762-A Method for preparing tertiary amine organic compound by photocatalytic decomposition of substituted formamide 天津理工大学 2021-01-05 — — CN disclosed
CN-106316945-B A kind of α of pefloxacin, alpha, beta-unsaturated ketone derivative and its preparation method and application 河南大学 2018-12-11 — — CN disclosed
CN-106316946-B A kind of α of Ciprofloxacin, alpha, beta-unsaturated ketone derivative and its preparation method and application 河南大学 2018-12-11 — — CN disclosed
EP-0773953-A1 COMBINATORIAL LIBRARIES OF MOLECULES AND METHODS FOR PRODUCING SAME THE SCRIPPS INSTITUTE (US) 1997-05-21 — — EP disclosed
US-5523296-A TREATING EYE HYPERTENSIVE CONDITION AFTER SURGERY, GLAUCOMA; SIDE EFFECT REDUCTION ALLERGAN, INC. (US) 1996-06-04 — — US disclosed
WO-1996003424-A1 COMBINATORIAL LIBRARIES OF MOLECULES AND METHODS FOR PRODUCING SAME THE SCRIPPS RESEARCH INSTITUTE (US) 1996-02-08 — — WO disclosed
EP-0292840-B1 Cyclic amine derivatives, medicaments containing these compounds and procedure for their preparation THOMAE GMBH DR K (DE) 1995-08-09 — — EP disclosed
US-5175157-A Cardiovascular disorders BOEHRINGER INGELHEIM GMBH (DE) 1992-12-29 — — US disclosed
EP-0292840-A2 Cyclic amine derivatives, medicaments containing these compounds and procedure for their preparation Dr. Karl Thomae GmbH (DE) 1988-11-30 — — EP disclosed
EP-0285356-A2 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1988-10-05 — — EP disclosed
EP-0126625-A2 Method for the production of phenolic compounds and resins SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-11-28 — — EP disclosed
US-4205084-A Control of insects with 2-ethyl-1,6-dioxaspiro[4.4]nonane FIRMENICH S.A. (CH) 1980-05-27 — — US disclosed
US-4087549-A Sulphonic acid containing indenyl derivatives MERCK & CO., INC. (US) 1978-05-02 — — US disclosed
Send feedback